PharmaEssentia Corporation PharmaEssentia Corporation

PharmaEssentia Corporation

6446

Hisse Senetlerindeki Sıralama #1442
PharmaEssentia Corporation is a biopharmaceutical firm dedicated to developing... PharmaEssentia Corporation is a biopharmaceutical firm dedicated to developing therapies for human ailments, serving both the Taiwanese and international markets. Its product portfolio prominently features Ropeginterferon alfa-2b, indicated for the management of various hematological conditions including chronic myelogenous leukemia, T-Cell leukemia, early myelofibrosis, polycythemia vera, and essential thrombocythemia. Beyond this, the company's pipeline includes TCRT, anti PD-1, PEG-cytokine X,Y, and novel checkpoint antibodies, all under development for solid tumors. A specific combination, P1101 + anti PD-1, is being explored for hepatocellular carcinoma, while PEG-GCSF addresses neutropenia. Fundamentally, its comprehensive research and development initiatives span key therapeutic areas such as hematology, infectious diseases, and oncology. Established in 1990, PharmaEssentia Corporation maintains its headquarters in Taipei, Taiwan.
Hisse Fiyatı
$36.89
Piyasa Değeri
$15.25B
Değişim (1 gün)
-1.28%
Değişim (1 yıl)
144.12%
Ülke
TW
Ticaret PharmaEssentia Corporation (6446)

Kategori

Healthcare
PharmaEssentia Corporation (6446) için hisse bölünme geçmişi
PharmaEssentia Corporation hissesi (sembol: 6446) toplamda 2 hisse bölünmesi yaşamıştır.
En son hisse bölünmesi Jul 09, 2026 tarihinde gerçekleşmiştir.
Sep 11, 2025 tarihinden önce alınan bir 6446 hissesi bugün 1.229881 6446 hissesine eşdeğerdir.
Hisse bölünme listesi
Yıl Bölünme Çarpan Kümülatif Çarpan
2026-07-09 1109:1000 x1.109 x1.229881
2025-09-11 1109:1000 x1.109 x1.109
Benzer şirketler veya rakipler için hisse bölünmeleri